Papers for

pharmaceutical analytics teams

Papers whose findings have a practical use for this group, as judged from the abstract. Open a paper to read what it means in practice.

ProCARE improves automation of real-world health studies with profile-based contracts

ProCARE: Real-World Study Automation via Profile-Grounded Evidence Contracts

Abstract: Real-world studies (RWS) analyze routinely collected healthcare data, such as electronic health records and insurance claims, to estimate treatment effects, monitor safety, and identify risk factors outside randomized trials. Automating RWS with large language model agents is appealing but brittle: valid analyses depend on dataset-specific clinical semantics, including index dates, follow-up windows, patient/event-level units, and outcome boundaries that are often implicit in observational data. This leads to schema mismatches, temporal errors, inconsistent analytical granularity, and unsupported clinical claims. We present ProCARE, a profile-grounded framework that reformulates RWS automation as constrained compilation. ProCARE converts heterogeneous data profiles into Evidence Contracts specifying available variables, temporal attributes, distributions, and evidentiary limits, and compiles study objectives into RWS-IR, a strongly typed intermediate representation for variables, time relations, analysis units, and statistical tasks. Deterministic validation and localized repair then check and revise generated workflows across schema mapping, cohort construction, variable derivation, analysis, and interpretation. On 36 EHR-based benchmark tasks, ProCARE outperforms strong LLM-agent baselines in code executability, semantic consistency, and conclusion traceability, with automated violation diagnoses showing moderate-to-substantial agreement with blinded expert review.

Mon 12 OctArtificial Intelligence
The gist
Real-world studies use routine health data to understand treatments and risks outside of clinical trials. Automating these studies is tricky because health data can be messy and structured very differently across databases. The authors created ProCARE, a system that makes automation smarter by outlining each dataset’s details in an “Evidence Contract” and then converting study goals into clear, checkable steps. This helps avoid errors and keeps analyses consistent. ProCARE was tested on many tasks and worked better than typical language model approaches at producing correct and trustworthy study workflows.
Open → 2610.16175v1

Model predicts continuous patient health changes using clinical history

Learning Continuous Patient Trajectories from Electronic Health Records

Abstract: Electronic health records provide irregular observations of latent patient states that evolve continuously over time. Recent autoregressive models condition on clinical histories to forecast future events as sequences of discrete observations. Conversely, multi-marginal flow matching provides a continuous-time formulation, but using multiple observations to supervise training paths does not itself give the learned dynamics access to preceding patient history. We introduce EHRFlow, a multi-marginal flow-matching framework that conditions on encoded patient history, thereby allowing future dynamics to depend on the patient's prior clinical trajectory. Our proposed framework accommodates irregular observation times and supports forecasting at arbitrary horizons. Across controlled synthetic benchmarks, EHRFlow improves clinical-code forecasting and latent-state recovery. On real-world clinical datasets comprising more than one million patients, including an independent external validation cohort, EHRFlow improves horizon-averaged top-5 clinical-code accuracy over autoregressive and history-independent flow-matching baselines. Finally, in a controlled counterfactual simulation, conditional guidance approximates the known effect of an antihypertensive intervention without training a task-specific outcome model.

Mon 28 SeptMachine Learning
The gist
Electronic health records capture patients' health over time, but the data is irregular and incomplete. The authors created a new model called EHRFlow that uses patient history to better predict future health events continuously over time. This model works even when observations are irregular and can forecast health conditions at any future time. Tests using both simulated and real patient data showed EHRFlow improves accuracy compared to previous methods. It can also simulate how treatments might affect a patient's health without needing a separate outcome model.
Open → 2609.36144v1

BioDyad synchronizes biomedical discovery and machine learning engineering

BioDyad: Synchronize Biomedical Discovery and Machine Learning Engineering

Abstract: Agentic biomedical machine learning (ML) draws on complementary advances in biomedical evidence acquisition and executable program search. Existing systems connect aspects of these capabilities, but coordinating them throughout program search remains challenging. New evidence must guide candidate construction, execution outcomes must inform subsequent discovery and reuse, and validation demands must fit the search budget. We introduce BioDyad, which couples biomedical discovery and ML engineering through two hierarchies within Monte Carlo graph search. Its scientific hierarchy combines prior biomedical guidance with iterative discovery, then links biomedical plans to execution outcomes in memory for reuse across candidates. Its engineering hierarchy moves candidate programs from smoke execution, through train/validation evaluation, to full-data retraining. We evaluate BioDyad on the 76-task BioXArena benchmark under a two-hour per-task budget with three matched LLM backends. It achieves the highest penalized all-task score and task success rate among four agent methods and a one-shot baseline under each backend. These results support coordinating biomedical discovery and ML engineering to integrate external knowledge into executable programs across heterogeneous biomedical tasks.

Fri 25 SeptArtificial Intelligence
The gist
Biomedical research often needs computer programs that can learn from data and also use the latest scientific knowledge. The authors created BioDyad, a system that helps combine new biomedical discoveries with the building and testing of machine learning programs. It carefully manages how evidence guides program creation and how the programs get trained and checked step-by-step. They tested BioDyad on many biomedical tasks and found it worked better than other similar methods, showing that linking discovery and engineering can improve biomedical AI.
Open → 2609.31939v1